Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, no par value, of Anchiano Therapeutics Ltd., and further agree that this Joint Filing Agreement be included as Exhibit 1 to such Schedule 13G. In evidence thereof, the undersigned hereby execute this agreement this 2nd day of January, 2020.
| GABRIEL CAPITAL MANAGEMENT LTD. | |||
| By: | /s/ Gabriel Leibler | ||
| Name: Gabriel Leibler | |||
| Title: Sole Director and Shareholder | |||
| SHAVIT CAPITAL FUND III (US), L.P. | |||
| By: Shavit Capital Fund 3 GP, L.P., as General Partner | |||
| By: Shavit Capital Fund 3 (G.P.) Ltd., its General Partner | |||
| By: | /s/ Gabriel Leibler | ||
| Name: Gabriel Leibler | |||
| Title: Director | |||
